Spots Global Cancer Trial Database for adenovirus
Every month we try and update this database with for adenovirus cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| An Exploratory Trial to Evaluate Efficacy and Safety for Combination Treatment of Adenovirus Double Suicide Gene Therapy | NCT04739046 | Pancreas Cancer | Theragene arm | 19 Years - 75 Years | Seoul National University Bundang Hospital | |
| An Exploratory Trial to Evaluate Efficacy and Safety for Combination Treatment of Adenovirus Double Suicide Gene Therapy | NCT04739046 | Pancreas Cancer | Theragene arm | 19 Years - 75 Years | Seoul National University Bundang Hospital | |
| A Clinical Trial of AdNRGM Plus CB1954 in Prostate Cancer | NCT04374240 | Prostate Cancer | AdNRGM | 18 Years - | University of Birmingham | |
| Chemoradiation With Enadenotucirev as a Radiosensitiser in Locally Advanced Rectal Cancer | NCT03916510 | Locally Advance... | Enadenotucirev Capecitabine Radiotherapy | 18 Years - | University of Oxford | |
| Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas | NCT00031083 | Glioblastoma Mu... Anaplastic Astr... Oligoastrocytom... Gliosarcoma | Interferon-beta | 18 Years - | Biogen | |
| LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer | NCT02705196 | Pancreatic Canc... | delolimogene mu... gemcitabine nab-paclitaxel atezolizumab | 18 Years - | Lokon Pharma AB | |
| Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma | NCT03072134 | Glioma Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... Glioblastoma Mu... Astrocytoma, Gr... Astrocytoma, Gr... Brain Cancer | Neural stem cel... | 18 Years - | Northwestern University | |
| Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer | NCT02654938 | Prostate Cancer | Mobilan (M-VM3) Placebo | 45 Years - 75 Years | Panacela Labs LLC | |
| Effect of AdhAQP1 on Salivary Flow in Patients Treated With Radiation for Head and Neck Cancer | NCT00372320 | Parotid Salivar... | Gene Transfer AdhAQP1 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| R-MVST Cells for Treatment of Viral Infections | NCT05183490 | Epstein-Barr Vi... Cytomegalovirus... Adenovirus BK Virus Infect... | Rapidly generat... | 18 Years - | Columbia University | |
| Effect of AdhAQP1 on Salivary Flow in Patients Treated With Radiation for Head and Neck Cancer | NCT00372320 | Parotid Salivar... | Gene Transfer AdhAQP1 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| TNFα and IL-2 Coding Oncolytic Adenovirus TILT-123 Monotherapy | NCT04695327 | Solid Tumor | TILT-123 | 18 Years - | TILT Biotherapeutics Ltd. | |
| Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care | NCT01431326 | Adenovirus Anesthesia Anxiety Anxiolysis Autism Autistic Disord... Bacterial Menin... Bacterial Septi... Benzodiazepine Bipolar Disorde... Bone and Joint ... Central Nervous... Convulsions Cytomegalovirus... Early-onset Sch... Epilepsy General Anesthe... Gynecologic Inf... Herpes Simplex ... Infantile Heman... Infection Inflammation Inflammatory Co... Intra-abdominal... Lower Respirato... Migraines Pain Pneumonia Schizophrenia Sedation Seizures Skeletal Muscle... Skin and Skin-s... Treatment-resis... Urinary Tract I... Withdrawal Sepsis Gram-negative I... Bradycardia Cardiac Arrest Cardiac Arrhyth... Staphylococcal ... Nosocomial Pneu... Neuromuscular B... Methicillin Res... Endocarditis Neutropenia Headache Fibrinolytic Bl... Pulmonary Arter... CMV Retinitis Hypertension Chronic Kidney ... Hyperaldosteron... Hypokalemia Heart Failure Hemophilia Heavy Menstrual... Insomnia | The POPS study ... | - 21 Years | Duke University | |
| Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder Cancer | NCT02143804 | Bladder Cancer High Grade Non Muscle Inva... | oncolytic adeno... | 18 Years - | CG Oncology, Inc. | |
| LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer | NCT02705196 | Pancreatic Canc... | delolimogene mu... gemcitabine nab-paclitaxel atezolizumab | 18 Years - | Lokon Pharma AB | |
| Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) | NCT00711035 | Adenovirus Infe... EBV Infection | Trivirus Specif... | - | Baylor College of Medicine | |
| A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors | NCT04673942 | Solid Tumor, Ad... Cancer Neoplasms Sarcoma Sarcoma,Soft Ti... Chondrosarcoma | AdAPT-001 Checkpoint Inhi... | 18 Years - | EpicentRx, Inc. | |
| Anti-viral T-cell Therapy by Gamma Capture | NCT06027879 | Adenovirus Cytomegalovirus... Epstein-Barr Vi... | Specific T- Lym... | 1 Month - 65 Years | University of Pittsburgh | |
| A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer | NCT02844699 | Prostate Cancer | Mobilan (M-VM3) Placebo | 45 Years - 75 Years | Panacela Labs LLC | |
| Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer | NCT02654938 | Prostate Cancer | Mobilan (M-VM3) Placebo | 45 Years - 75 Years | Panacela Labs LLC | |
| Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma | NCT01864759 | Locally Advance... | ICOVIR-5 | 18 Years - | Institut Català d'Oncologia | |
| R-MVST Cells for Treatment of Viral Infections | NCT05183490 | Epstein-Barr Vi... Cytomegalovirus... Adenovirus BK Virus Infect... | Rapidly generat... | 18 Years - | Columbia University | |
| Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care | NCT01431326 | Adenovirus Anesthesia Anxiety Anxiolysis Autism Autistic Disord... Bacterial Menin... Bacterial Septi... Benzodiazepine Bipolar Disorde... Bone and Joint ... Central Nervous... Convulsions Cytomegalovirus... Early-onset Sch... Epilepsy General Anesthe... Gynecologic Inf... Herpes Simplex ... Infantile Heman... Infection Inflammation Inflammatory Co... Intra-abdominal... Lower Respirato... Migraines Pain Pneumonia Schizophrenia Sedation Seizures Skeletal Muscle... Skin and Skin-s... Treatment-resis... Urinary Tract I... Withdrawal Sepsis Gram-negative I... Bradycardia Cardiac Arrest Cardiac Arrhyth... Staphylococcal ... Nosocomial Pneu... Neuromuscular B... Methicillin Res... Endocarditis Neutropenia Headache Fibrinolytic Bl... Pulmonary Arter... CMV Retinitis Hypertension Chronic Kidney ... Hyperaldosteron... Hypokalemia Heart Failure Hemophilia Heavy Menstrual... Insomnia | The POPS study ... | - 21 Years | Duke University | |
| A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Malignant Solid Tumors | NCT06215846 | Solid Tumor | BioTTT001 injec... | 18 Years - 70 Years | Beijing Bio-Targeting Therapeutics Technology Co., Ltd | |
| Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder Cancer | NCT02143804 | Bladder Cancer High Grade Non Muscle Inva... | oncolytic adeno... | 18 Years - | CG Oncology, Inc. | |
| Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections | NCT02231853 | Chronic Lymphoc... CML (Chronic My... MDS (Myelodyspl... Acute Lymphobla... AML (Acute Myel... | MVST MVSTr | 18 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH) | NCT01945619 | EBV Infection CMV Infection Adenoviral Infe... | Trivirus-Specif... | - | Baylor College of Medicine | |
| A Clinical Trial of AdNRGM Plus CB1954 in Prostate Cancer | NCT04374240 | Prostate Cancer | AdNRGM | 18 Years - | University of Birmingham | |
| Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor | NCT00262327 | Advanced Solid ... | Antangiogenesis endostatin gene | 18 Years - 65 Years | Sun Yat-sen University | |
| Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) | NCT00711035 | Adenovirus Infe... EBV Infection | Trivirus Specif... | - | Baylor College of Medicine | |
| Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer | NCT02654938 | Prostate Cancer | Mobilan (M-VM3) Placebo | 45 Years - 75 Years | Panacela Labs LLC | |
| Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV | NCT01535885 | Epstein-Barr Vi... Adenovirus Cytomegalovirus... | Cytotoxic T Lym... | - 22 Years | Medical College of Wisconsin | |
| A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer | NCT02844699 | Prostate Cancer | Mobilan (M-VM3) Placebo | 45 Years - 75 Years | Panacela Labs LLC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
